Speech-Language Pathologists in Dora, NM Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Mrs. Mary Kaye Maloney, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 School Street, Dora Consolidated Schools, Dora, NM 88115 Phone: 505-477-2211 |
Mrs. Shaelei Brooke Lemons Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 School St, Dora, NM 88115 Phone: 575-477-2211 |
News Archive
New paper documents discovery of novel lipids, including MC3
Alnylam Pharmaceuticals, a leading RNAi therapeutics company, and collaborators announced today the publication of a scientific paper documenting the discovery of novel lipids used in second generation lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
Biotransformed blueberry juice can function as anti-obesity and anti-diabetic agent
Juice extracted from North American lowbush blueberries, biotransformed with bacteria from the skin of the fruit, holds great promise as an anti-obesity and anti-diabetic agent. The study, published in the International Journal of Obesity, was conducted by researchers from the Universit- de Montr-al, the Institut Armand-Frappier and the Universit- de Moncton who tested the effects of biotransformed juices compared to regular blueberry drinks on mice.
Study: Employees with influenza have more lost work time
Employees with laboratory-confirmed influenza have more lost work time- including absences and reduced productivity while at work- compared to those with other types of acute respiratory illness (ARI), reports a study in the December Journal of Occupational and Environmental Medicine.
Scientists develop new class of molecules that provide new way to attack bacteria resistant to antibiotics
As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides - ADEPs - kills bacteria in a way that no marketed antibacterial drug does - by altering the pathway through which cells rid themselves of harmful proteins.
Philip and Cheryl Milstein provide $20M to support advancement of medicine at CUMC
Continuing their family's multigenerational connection to Columbia and support of its leadership in medicine, Philip (CC '71) and Cheryl Milstein (Barnard '82) have made a $20 million commitment to Columbia University Medical Center.
› Verified 4 days ago